Narcolepsy or Idiopathic Hypersomnia (CRYSTAL-1) - Clinical Research Study
Summary
A study to evaluate how well a the study drug, ORX750, works as a possible treatment for sleep-wake disorders, such as narcolepsy and idiopathic hypersomnia.
Eligibility
Eligible ages: 18 to 65
Inclusion criteria:
You may be eligible if:
- you are 18 to 65 years of age
- have been diagnosed with narcolepsy or hypersomnia
Exclusion criteria:
You may not be eligible to participate if:
- you do not have narcolepsy or hypersomnia
- you are under the age of 18
- you are currently pregnant, planning to become pregnant in the near future, or breastfeeding.
Participate
Additional information
Contact information
Please contact the study doctor, Dr. Marcus Povitz at mpovitz@ucalgary.ca, or the study coordinator, Jill Raneri at jkraneri@ucalgary.ca or by phone at 403-519-6591.
Principal investigator:
Marcus Povitz
Clinical trial:
Yes
REB-ID:
REB25-0530